FR2541116B1 - Procede pour la preparation de vaccins polyvalents (tetanos, diphterie, coqueluche) adsorbes lyophilises - Google Patents

Procede pour la preparation de vaccins polyvalents (tetanos, diphterie, coqueluche) adsorbes lyophilises

Info

Publication number
FR2541116B1
FR2541116B1 FR8402511A FR8402511A FR2541116B1 FR 2541116 B1 FR2541116 B1 FR 2541116B1 FR 8402511 A FR8402511 A FR 8402511A FR 8402511 A FR8402511 A FR 8402511A FR 2541116 B1 FR2541116 B1 FR 2541116B1
Authority
FR
France
Prior art keywords
coqueluche
tetanos
adsorbes
diphteria
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8402511A
Other languages
English (en)
Other versions
FR2541116A1 (fr
Inventor
Zoltan Csizer
Karoly Sikos
Laszlo Bacskai
Istvan Joo
Eleonora Niedermayer
Lajos Rethy
Jozsef Zsidai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HUMAN OLTOANYAGTERMELO
Original Assignee
HUMAN OLTOANYAGTERMELO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUMAN OLTOANYAGTERMELO filed Critical HUMAN OLTOANYAGTERMELO
Publication of FR2541116A1 publication Critical patent/FR2541116A1/fr
Application granted granted Critical
Publication of FR2541116B1 publication Critical patent/FR2541116B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0016—Combination vaccines based on diphtheria-tetanus-pertussis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FR8402511A 1983-02-22 1984-02-20 Procede pour la preparation de vaccins polyvalents (tetanos, diphterie, coqueluche) adsorbes lyophilises Expired FR2541116B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU83609A HU188847B (en) 1983-02-22 1983-02-22 Process for producing liophylized combined vaccines

Publications (2)

Publication Number Publication Date
FR2541116A1 FR2541116A1 (fr) 1984-08-24
FR2541116B1 true FR2541116B1 (fr) 1988-07-15

Family

ID=10950430

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8402511A Expired FR2541116B1 (fr) 1983-02-22 1984-02-20 Procede pour la preparation de vaccins polyvalents (tetanos, diphterie, coqueluche) adsorbes lyophilises

Country Status (18)

Country Link
US (1) US4578270A (fr)
JP (1) JPS59196821A (fr)
BE (1) BE898955A (fr)
CA (1) CA1234048A (fr)
CH (1) CH663901A5 (fr)
CS (1) CS272759B2 (fr)
DD (1) DD216384A5 (fr)
DE (1) DE3406419A1 (fr)
DK (1) DK82784A (fr)
ES (1) ES529961A0 (fr)
FR (1) FR2541116B1 (fr)
GB (1) GB2135190B (fr)
HU (1) HU188847B (fr)
IT (1) IT1196032B (fr)
NL (1) NL8400511A (fr)
PL (1) PL246306A1 (fr)
PT (1) PT78132B (fr)
YU (1) YU33284A (fr)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
JPS62162963A (ja) * 1986-01-10 1987-07-18 Sadao Shiosaka 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4762710A (en) * 1986-06-16 1988-08-09 The United States Of America As Represented By The Department Of Health And Human Services Novel method of preparing toxoid by oxidation and metal ions
US5139776A (en) * 1987-04-24 1992-08-18 The Research Foundation For Microbial Diseases Of Osaka University Method for culturing Bordetella pertussis, a pertussis toxoid and a pertussis vaccine
CA1337859C (fr) * 1987-04-24 1996-01-02 Masashi Chazono Methode pour la culture de bordetella pertussis permettant d'obtenir l'anatoxine et un vaccin de la coqueluche
US5290563A (en) * 1989-07-27 1994-03-01 Laboratoire Des Stallergenes Method for combining a mixture of heterogeneous substances with liposomes
MX170503B (es) * 1990-05-10 1993-08-26 Univ Mexico , "procedimiento para obtener un reactivo antigenico util para determinar indirectamente salmonella typhi.
GB9125695D0 (en) * 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
NZ259285A (en) * 1993-01-08 1996-07-26 Csl Ltd Vaccine preparations in stable particulate form comprising an immunogen absorbed to an aluminium salt adjuvant or biodegradable polymer matrix
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US5902565A (en) * 1993-12-24 1999-05-11 Csl Limited Spray dried vaccine preparation comprising aluminium adsorbed immunogens
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6407218B1 (en) * 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
GB2342922B (en) * 1998-10-19 2002-12-24 Jeyes Group Plc Lavatory cleansing block
US6592869B2 (en) * 1999-08-24 2003-07-15 Teva Pharmaceutical Industries, Ltd. Vaccine composition and method of using the same
IL148247A0 (en) * 1999-08-24 2002-09-12 Teva Pharma A vaccine composition and method of using the same
PT1253932E (pt) * 2000-02-08 2005-07-29 Allergan Inc Composicoes farmaceuticas de toxina botulinica
US7780967B2 (en) * 2000-02-08 2010-08-24 Allergan, Inc. Reduced toxicity Clostridial toxin pharmaceutical compositions
US20030118598A1 (en) * 2000-02-08 2003-06-26 Allergan, Inc. Clostridial toxin pharmaceutical compositions
US20060269575A1 (en) * 2000-02-08 2006-11-30 Allergan, Inc. Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
US20030138460A1 (en) * 2000-02-08 2003-07-24 Allergan, Inc Methods of treating animals with botulinum toxin pharmaceutical compositions
US8632785B2 (en) * 2000-02-08 2014-01-21 Allergan, Inc. Clostridial toxin pharmaceutical composition containing a gelatin fragment
US20020120228A1 (en) * 2000-06-08 2002-08-29 Yuh-Fun Maa Powder compositions
JP2003535119A (ja) * 2000-06-08 2003-11-25 パウダージェクト ワクチンズ，インコーポレーテッド 粉末組成物
US20040213798A1 (en) * 2000-06-08 2004-10-28 Powderject Vaccines, Inc. Spray-dried alum compositions
KR100401423B1 (ko) * 2001-01-10 2003-10-17 주식회사 엘지생명과학 혼합 백신의 제조 방법
JP2004532277A (ja) * 2001-06-08 2004-10-21 パウダージェクト ワクチンズ，インコーポレーテッド 噴霧凍結乾燥組成物
JP2008504216A (ja) * 2003-12-02 2008-02-14 サイトイミューン サイエンシズ インコーポレイテッド モノクローナル抗体の生成のための方法および組成物
CA2554755A1 (fr) * 2004-01-28 2005-08-11 Cytimmune Sciences, Inc. Compositions metalliques colloidales fonctionnalisees
CA2624503A1 (fr) 2005-10-04 2007-04-12 Alk-Abello A/S Formulation vaccinale solide
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
US20090104114A1 (en) * 2007-09-21 2009-04-23 Cytimmune Sciences, Inc. Nanotherapeutic Colloidal Metal Compositions and Methods
CA2706700A1 (fr) 2007-11-08 2009-05-14 Cytimmune Sciences, Inc. Compositions et procedes de production d'anticorps
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
GB0916570D0 (en) * 2009-09-21 2009-10-28 Royal Holloway & Bedford New C Method

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2085391A (en) * 1934-01-31 1937-06-29 Sharp & Dohme Inc Lyophilic biologically active substances and process of producing the same
US3097140A (en) * 1958-10-31 1963-07-09 Merck & Co Inc Preparing a mixed polio, pertussis, tetanus, and diphtheria vaccine with benzethonium chloride
GB895073A (en) * 1959-11-23 1962-05-02 Wellcome Found Immunising preparations containing clostridium perfringens toxins and toxoids
US3395219A (en) * 1964-12-11 1968-07-30 Merck & Co Inc Process for production of pertussis antigen
NL6600706A (fr) * 1965-02-05 1966-08-08
GB1081796A (en) * 1965-08-13 1967-08-31 Wright Fleming Inst Of Microbi Improvements in or relating to oily adjuvants for water-in-oil emulsions of antigenic materials
US3405218A (en) * 1965-09-22 1968-10-08 Parke Davis & Co Extracting bordetella pertussis antigens with lithium bromide
GB1145320A (en) * 1966-05-20 1969-03-12 Ustav Ser A Ockovacich Latek O Process for the preparation of bacterial cultures for vaccines against pertussis and
GB1152607A (en) * 1967-03-08 1969-05-21 Pfizer Ltd Antigenic Compositions
GB1218277A (en) * 1968-08-20 1971-01-06 Miles Lab Dry water-dispersible aluminium hydroxide gels
US3599150A (en) * 1969-08-01 1971-08-10 Miles Lab Stabilized aluminum hydroxide suspensions
FR2181426B1 (fr) * 1972-04-06 1974-12-20 Pasteur Institut
FR2227861B1 (fr) * 1973-05-04 1976-07-02 Anvar
DE2355094C3 (de) * 1973-11-03 1979-05-23 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines Tetanus-Impfstoffs
DE2461439C3 (de) * 1974-12-24 1980-03-20 Behringwerke Ag, 3550 Marburg Verfahren zur Herstellung eines schützenden Antigens von Bordetella Pertussis sowie jenes enthaltendes Mittel
JPS5296729A (en) * 1976-02-05 1977-08-13 Shionogi & Co Ltd Mixed vaccin for cyanomycosis
US4273762A (en) * 1979-12-03 1981-06-16 Merck & Co., Inc. Lyophilization process for live viral compositions
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines

Also Published As

Publication number Publication date
GB8403921D0 (en) 1984-03-21
JPS59196821A (ja) 1984-11-08
DK82784A (da) 1984-08-23
DD216384A5 (de) 1984-12-12
GB2135190B (en) 1986-10-22
YU33284A (en) 1987-10-31
PT78132B (en) 1986-05-19
BE898955A (fr) 1984-08-20
CH663901A5 (de) 1988-01-29
DE3406419A1 (de) 1984-08-23
PL246306A1 (en) 1985-02-27
ES8506451A1 (es) 1985-07-16
CA1234048A (fr) 1988-03-15
FR2541116A1 (fr) 1984-08-24
NL8400511A (nl) 1984-09-17
DK82784D0 (da) 1984-02-21
IT1196032B (it) 1988-11-10
HU188847B (en) 1986-05-28
PT78132A (en) 1984-03-01
ES529961A0 (es) 1985-07-16
IT8419729A0 (it) 1984-02-21
CS272759B2 (en) 1991-02-12
GB2135190A (en) 1984-08-30
US4578270A (en) 1986-03-25
CS122584A2 (en) 1990-06-13

Similar Documents

Publication Publication Date Title
FR2541116B1 (fr) Procede pour la preparation de vaccins polyvalents (tetanos, diphterie, coqueluche) adsorbes lyophilises
ES2021699B3 (es) Proceso para la preparacion de esteres.
RO86363A (fr) Procede pour la preparation des derives de methylthiopyrimidine
MA22381A1 (fr) Procede de production de vaccins
RO86851A (fr) Procede pour la preparation des derives de pyperazin-2-one
RO89235A (fr) Procede pour la preparation des derives de thilosine
MC1527A1 (fr) Procede pour la preparation de derives de 1-sulfo-2-oxoazetidine
MA19783A1 (fr) Procede de preparation de benzoazacycloalkyl-spiro-imidazolidines.
FR2599369B1 (fr) Procede de preparation de disilylmethanes
MA21984A1 (fr) Procede pour la preparation de derives de quilinone .
RO85384A (fr) Procede de preparation des derives de la pyridine
FR2626883B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique
FR2609027B1 (fr) Procede de preparation de mercaptoalcools
FR2525219B1 (fr) Procede pour la preparation de 4-hydroxy-2-methyl-2h-1,2-benzothiazine-3-carboxamide-1-1-dioxydes
FR2550190B1 (fr) Procede de preparation de b-phenylserine
MA20092A1 (fr) Procede de preparation de derives de pyrimidinetrione.
FR2549042B1 (fr) Procede pour la preparation de la 3,11-dimethyl-2-nonacosanone
FR2634765B1 (fr) Procede pour la preparation de levo- et de dextro-dropropizine
FR2604703B1 (fr) Procede de preparation de polyfluoroenolates
FR2600333B1 (fr) Procede pour la preparation de 4-alcoxy-3-pyrroline-2-ones
NL191821C (nl) Werkwijze voor de bereiding van gefermenteerde melkprodukten.
FR2550790B1 (fr) Procede de preparation de la 4-methylionone
FR2540108B1 (fr) Procede de preparation de perhalogenoalkylthioethers
FR2663320B1 (fr) Procede de preparation de dialcoxybutenes.
FR2543957B1 (fr) Procede de preparation de la bacampicilline

Legal Events

Date Code Title Description
ST Notification of lapse